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Localization of pain sensitization has clinical importance, however, rarely been assessed in 
amputees. The objective of this study was to investigate the sensitivity of pain over the residual 
limb and its variability among veterans with transtibial amputation. Pain sensitivity in 12 
locations was explored twice in 19 veteran amputees using pressure algometry. The lowest 
pressure pain threshold (PPT) and pressure tolerance (PT) was recorded at the distal end of the 
residual limb (20.5 and 33 Ncm
-2
, p=0.13), and the highest PPT and PT was recorded at the mid-
patellar tendon (73.4 and 94.3 Ncm
-2
, p=0.03). There was a significant moderate correlation 
(r=0.48-0.52) between pressure pain and daily hours of prosthesis use. A localized pattern for 
sensitivity to pain over the transtibial residual limb was obtained that can be used to improve the 
transtibial socket design and fit as well as the selection of prevention, evaluation, and treatment 
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Chapter 1: Review of Literature‎ 
 
1.1: Introduction 
Hundreds of thousands of people experience severe morbidities, traumatic 
injuries, and disorders that lead to a limb amputation each year.
1
 Moreover, an increasing 
number of combats and armed conflicts in recent decades were associated with increased 
casualties
2
 and the number of survived military service members with limb amputations.
3-
5
 Lower limb amputations, particularly at the below knee (transtibial) level accounts for 
the majority of amputations in military service members.
6
  
Pain is a common devastating impairment after limb amputation that affects the 
person for the remainder of their life.
7,8
 Pain in the remaining part of the amputated limb 
(residual limb) and in the amputated part of the limb (phantom limb) is two general kinds 
of pain in people with amputation. Amputees who suffer residual limb pain may avoid 
participating in physical and social activities, which consequently, may endanger their 
general health and quality of life.
9,10
 Little information regarding sources of residual limb 
pain, its associated factors and quantification methods are available in the literature. 
Controlling residual limb pain has therapeutic and rehabilitative significance. However, 
quantification of pain over the residual limb is challenging due to its direct contact to the 
prosthetic socket, biomechanics of the interface, and fluctuating size (i.e. volume and 
shape) of the residual limb over short and long terms.
11
 Although there are numerous 
studies that focus on the residual limb-socket interface pressure measurements and 
estimation,
12-14






Pain sensitivity can be measured through pressure pain algometry, which is the 
quantification of pressure (force) applied to the skin to cause pain over specific points in 
the body.
17
 This study explores the sensitivity of pressure pain threshold and pain 
tolerance over the transtibial residual limb. Furthermore, it investigates the variability of 
pain among transtibial amputees, and evaluates the relationship of clinical and/or 
demographic characteristics of transtibial amputees with their pain sensitivity. A potential 
application for determination of localized pain over the transtibial residual limb, could be 
improving the prosthetic socket design and fit, as well as the selection of prevention, 
evaluation, and treatment methods for the residual limb pain. 
 
1.2. Limb Amputation Statistics 
Limb amputation is globally increasing due to growing number of traumas (e.g. 
accidents and wars), vascular pathologies, and advancing surgical and therapeutic 
techniques to surviving patients from previous mortality conditions.
1,18
 It is difficult to 
get prevalence estimates of amputation due to limited and incomplete national and 
international disability databases.
19
 In 2009, it was reported that globally about 30 million 
people were living with limb loss.
20
 In the United States, nearly 1.6 million amputees are 
living based on 2005 reports.
21
 Furthermore, based on the healthcare data from 1988 
through 1996, dysvascular amputation accounted for 82% of limb loss discharges with 
27% increase in rate over all years.
22
 However, more recent studies reported that the 
prevalence of limb loss exclusively due to peripheral arterial disease and diabetes are 
decreasing and instead a cumulative illness burden from different disorders and diseases 
leads amputation rates.
23
 In United Kingdom it has been reported that trauma stands at 
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second rank following dysvascular etiology for lower limb amputations. However, for 
upper limb amputations, trauma is still the first etiologic rank.
24
 It is estimated that 
amputee population in United States will increase to 3.6 million by 2050.
21
 In Canada, 
there were 44,430 new lower limb amputations from 2006 to 2012 with increasing 
numbers each year.
25
 In the United Kingdom about 55,000 to 60,000 patients are living 
with limb loss and congenital deficiencies who use rehabilitation services.
26
 Moreover, in 
United Kingdom there is about 5000 new referrals to prosthetic service centers each 
year.
26
 Lower limb amputation is the main level of amputation and subsequently the 
transtibial amputation accounts for more than 50% of lower limb amputations.
24
 
Regardless of amputation cause, age, gender, and race are affecting the prevalence of 
amputations.
23,27
 These statistics could indicate high demands for amputee care and 
prostheses in near future. It could be estimated that the need for prostheses, orthoses, and 
other assistive devices is increasing. Nearly 30 million people in Africa, Asia, and Latin 




1.3. Amputations in Veterans Population 
An increasing number of combats and armed conflicts in recent decades was 
associated with an increase in casualties.
2
 Although improvement of protective gears and 
medical practices has greatly decreased war-related mortality rates, the number of 
survived military service members with limb amputation has increased.
3-5
 Based on a 
governmental report in 2015 for the United States, there were 1,645 veterans who 
suffered an amputation during war against terrorism.
28
 Reports of the United Kingdom 
indicated there were 234 veterans who sustained an amputation during service through 
4 
 
Iraq, Afghanistan or other regions from 2001 through 2015.
29
 The reason of limb loss in 
military servicemen could be attributed to combat traumas or training accidents, traumas 
occurring when serving off-duty, and systematic and chronic illnesses especially in 
former personnel.
30
 For the Iraq-Iran war, it was reported that about 90% of amputations 
happened due to land mine explosions.
31
 Lower limb amputations, particularly at the 
below knee level account for the majority of amputations in military service members.
6
 
Based on the report of the Iranian Veterans and Martyrs Affairs Foundation (VMAF), 
there were 11,570 veterans who sustained lower limb amputations during Iraq-Iran war.
32
 
The veteran amputee population differs from general amputee population due to their 
multiple associated disorders and injuries. Psychological, cardiac, nervous, 
gastrointestinal, respiratory, and musculoskeletal disorders can be found at different 
levels among many veterans.
32,33
 In addition, back pain, joint pain, osteoarthritis, and 




1.4. Post-Amputation Management 
Limb amputation is a devastating experience that can physically and 
psychologically affect the life style of a person. Impaired mobility, limited exercise and 
social activity, depression, post-traumatic stress disorder, and usually the systematic 
comorbidities are general sequelae to lower limb amputation that are well-known as 
“post-amputation syndrome”.
35
 Post-amputation syndrome in lower limb amputees can be 
sub-divided into three categories: amputated limb issues (e.g. surgical wound healing, 
post-amputation pain, skin disorders, and musculoskeletal disorders), contralateral side to 
the amputated limb issues (e.g. osteoarthritis of the lower limb joints, and excess energy 
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expenditure) and systematic problems (e.g. balance and gait abnormality, low back pain, 




Rehabilitation is a purposeful process to enable persons with disabilities to regain 
their functional independence at the mental, physical, psychological, and social levels.
36
 
Post-amputation rehabilitation is an intervention based on educational and problem-
solving clinical views that aims to lessen multimodal issues of amputees and to help them 
regain their functional independence.
24
 Immediately after amputation surgery, post-
amputation management starts and continues for the remainder of the amputee’s life. The 
most important tasks of post-operative amputation management are to rapidly heal the 
wound, control edema, control pain, prevent joint contracture, control the shape and 
volume of the residual limb (stump), rapid rehabilitation to resume the independence of 
the patient in daily activities, and prevention of depression.
8
 Chronic pain is a secondary 
disabling condition after amputation surgery that negatively affects the quality of life, 
impedes rehabilitation, and diminishes prosthesis use in these patients. Living with 
chronic pain can affect the outlook, personality and relationships of an amputee.
37
 
Following the intensive post-operative care, the rehabilitation process continues with 
main focus on improving function and comfort in amputee.
8
 The residual limb gradually 
matures in volume and shape when inflammations are suppressed and wound sites healed. 
Gradually, the preliminary soft and interim prostheses are replaced with rigid and 
permanent (final) prostheses, which provide transferring patient’s load and help to sturdy 







1.5. Issues of Current Transtibial Prostheses 
Transtibial prostheses are categorized based on their general design as exoskeletal 
or endoskeletal (Figure 1). The exoskeletal prosthesis has a hard outer shell that provides 
structural strength and cosmetic appearance. Endoskeletal prosthesis has a modular 
structure shaped by assembling different components that finally covered by a cosmetic 
foam.
39
 An ordinary endoskeletal transtibial prosthesis includes a prosthetic socket, 
suspension system, pylon, foot and ankle components.
39
  
Socket is the main component of the prosthesis that surrounds the residual limb 
and primarily provides structural coupling, control, and proper transfer of forces and 
motions at its interface with residual limb.
40
 Stable mechanical coupling between residual 
limb and prosthesis is a prerequisite for the sense of stability for the amputee during 
standing and walking. Such stability sense is achievable by high interface stresses over 
the skin of the transtibial residual limb that is not intended to tolerate the stresses of 
weight bearing, i.e. unlike the skin of the sole of the foot.
1
 The interface of the residual 
limb-socket is under two kinds of compressive stresses: perpendicular (i.e. pressure) and 
tangential to the skin surface (i.e. shear). Stresses higher than a certain level and duration 
cause skin breakdown and consequently lead to discomfort and pressure ulcer.
1
 The 
response of the skin to pressure is reduction of perfusion that can lead to ischemia and 
tissue necrosis. It was shown that under static loading the muscle tissue, due to higher 
vascularity and metabolic demand, is more vulnerable to tissue necrosis than skin. 
Therefore, it would be highly probable that someone may have deep soft tissue injury 
while there is no skin manifestation. With respect to shear stress, the response of skin 
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depends on how stress is applied. Friction and tangential are two common kinds of shear 
stresses at the residual limb-socket interface that can lead to blister formation and reduced 
local stress concentration, respectively.
41
  
A major problem of most prosthetic sockets is their inability to adapt to the short 
term and long term changes of the shape and volume of the residual limb. Short term 
(diurnal) changes are cyclic and happen on a daily basis from morning to the evening due 
to movement of the extracellular fluid.
42,43
 During walking, hard walls of the socket act as 
a pump to push fluid out of the interstitial spaces leading to shrinkage of the residual limb 
over the course of a day. However, doffing prosthesis removes the rigid constraint over 
the residual limb, and resting for sufficient time will allow it to return to the primary 
size.
42
 With respect to long term changes, they happen over weeks or months mainly due 
to a variety of reasons including large weight changes, maturation of the residual limb, 
changes in vascular condition of the amputee, and even muscle atrophy.
1
 Usually, long 
term changes of the residual limb are not easily reversible and force the amputee to 
change the prosthetic socket.  
Socket comfort directly impacts function and extent of prosthesis use in 
amputees.
44,45
 Suspension system refers to the components that aim to keep prosthesis 
retention and provide safe and well-functioning prosthesis by suspending that over the 
residual limb.
46
 Good prosthesis suspension requires a snug total contact fit that 
consequently limits ventilation and air circulation at socket-skin interface. Limited 
ventilation and low moisture permeability of the prosthetic socket walls contribute in 
increasing the residual limb skin temperature and perspiration accumulation inside 
prosthetic socket. These consequences could negatively affect the quality of life, 
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prosthesis suspension, prosthesis use and activity level. Moreover they cause discomfort, 
skin irritation, skin maceration, friction blisters, infection, unpleasant odor, and an 
unpleasant environment for bacterial invasion to hair follicles of the residual limb.
44,47-61
  
Residual limb skin care is important to a great extent such that any skin irritation 
could endanger load bearing and prosthesis use in spite of appropriate socket fit.
59,62,63
 
Skin problems that easily could be seen in amputees include those with mechanical 
sources (epidermoid, cysts, calluses, verrucous hyperplasia), allergic reactions 
(inflammation, eczema, contact dermatitis, rash), and fungal or bacterial infections.
58,64,65
 
The incidence of at least one skin problem is estimated to be between 34-74%.
50
 
Therefore, key factors in successful use of prosthesis include skin integrity of the residual 
limb, its health and hygiene.
66,67
 Skin irritation, ulceration, dermatitis, are major sources 
of the residual limb pain and besides excessive sweating are common complaints of 
amputees who use prostheses for their daily activities.
68,69
 Legro et al in their survey 
determined that from the amputees’ point of view, prevention of skin blisters is one of 
their three most important issues in prosthesis use.
60
 Intermittent pressure and shear 
stresses relief when followed by exercises could lead to remodeling and adaptation of the 
soft tissues to repetitive stresses.
1
    
Using a socket is not the sole method to link the residual limb to prosthesis. 
Osseointegration is another method used for the linkage and its popularity is increasing in 
North America and some parts of Europe. However, due to potential risks of infection 
and periprosthetic fracture, and high cost of the associated surgery, this method has not 
been globally accepted.
70
 Therefore, using the prosthetic socket is still the main method 




1.6. Pain Definition and Classification 
Pain has been defined by the International Association for the Study of Pain as 
“an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage or described in terms of such damage”.
71
 Pain is a dichotomous 
phenomenon that acts like a double-side sword that may help us in the short term 
following injury but disables us when it becomes chronic and long term stimulation.
72
 
Pain is a devastating impairment that decreases the quality of life of a person.
7,8
 
Debilitating pain can present the community with extra costs in treatment and lost 
productivity of patients.
73
 Although complex and under debate, four mechanism-based 
classifications of pain are available based on the dominant neurophysiological events that 
lead to pain generation and its maintenance. These mechanisms are: nociceptive, 
peripheral neuropathic, central sensitisation, and psychosocial.
74,75
 Nociceptive pain 
refers to pain attributed to the activation of peripheral receptive terminals of the primary 
afferent neurons in response to painful thermal, mechanical, or chemical (pro-
inflammatory chemicals released in response to injury or pathology, as well as lowering 
of tissue pH in response to tissue ischemia due to static loading) stimuli.
75
 Peripheral 
neuropathic pain is attributed to the pain arising from a primary lesion or dysfunction in 
the peripheral nervous system.
76
 Central sensitisation pain refers to neurophysiological 
dysfunctions in the central nervous system (at the cellular level within spinal cord and/or 
supraspinal centers) the lead to pain sensation.
77
 In other words, central sensitisation pain 
is attributed to amplification of neural signalling and regulation of the nociceptive system 
in different ways including enhanced synaptic excitability, reduced synaptic inhibition, 
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lowered receptors’ thresholds of activation, and expanded receptive fields of the central 
neurons, which all elicit pain hypersensitivity.
77-79
 The net effect of the central 
sensitization is recruitment of sub-threshold inputs to the nociceptive receptors to 
generate an augmented action potential output.
79
 Central sensitization happens as a result 
of plastic changes in properties of the central neurons, which consequently leads to 
hypersensitivity of the sensory receptors. Therefore, central sensitization pain is not 
reliant on presence, intensity, or duration of the noxious stimuli. It happens independently 
in presence of normal input to the nociceptive receptors.
79
 Psychosocial pain refers to 
pain arising from cognitive, affective, behavioural, and social factors that modulate 
experience and perception of pain. For instance, the self-reported intensity of pain might 
be different in presence of a friend during experimental pain assessment.
72
            
Another classification for pain is acute, post-operative, neuropathic, terminal (e.g. 
cancerous), psychogenic, and chronic.
80
 Acute pain is an immediate response to an injury 
or illness and will gradually resolve during healing process; however, chronic pain has a 





1.7. Post-Amputation Pain 
Pain in the residual limb may prevent amputees from participating in physical and 
social activities; consequently, their general health and quality of life may be 
jeopardized.
9,10
 Post-amputation pain is highly prevalent and challenging for treatment 
regardless of time since amputation.
27,82
 In a national survey of 914 amputees in the 
United States, almost all (95%) amputees reported experiencing at least one kind of 
11 
 
amputation-related pain in the last month.
82
 The pathophysiologic basis of post-
amputation pain can be described by supraspinal, spinal, and peripheral mechanisms.
27
 
Supraspinal mechanisms involve cortical reorganization of the brain map, where 
sprouting neurons from adjacent maps invade the deafferentated brain map.
83
 The upper 
limit of somatosensory cortical maps reorganization for a short-term deafferentaion is 
about 1-2 millimeters mediolaterally, however, for the long-term deafferentation, it 
exceeds greatly from the upper limit.
84
 It was reported that descending inhibition 
decreases with deafferentation and there is the possibility that some CNS structures like 
dorsal column nuclei, thalamus, cortex, and reticular formation are involved in 
pathogenesis of pain.
85
 Spinal mechanisms involve reorganization at the dorsal horn 
when afferent signals from a peripheral nerve ceases. Loss of the afferent input to the 
dorsal horn associated with decreased impulses from the brainstem reticular formation, as 
well as absence of inhibitory effect for sensory input from the amputated part, which 
consequently leads to increased autonomous activity of the dorsal horn neurons known as 
sensory epileptic discharges.
27,85,86
 This process occurs in detail by a series of plastic 
changes occurring at the dorsal horn including death of many dorsal root ganglion cells, 
some trans-synaptic changes, decreased myelination, neuropeptide level changes, 
biochemical changes in the dendritic tree, and some sprouting of neurons within the 
dorsal horn.
27,85,87
 Finally, peripheral mechanisms involve initiation of axonal 
inflammation after injury, regeneration of axon, sprouting nerves, and increased abnormal 
afferent inputs.
27,85
 Axonal regeneration associated with changes in expression of 
transduction molecules, up-regulation of voltage-sensitive sodium channels, and down-
regulation of potassium channels that all together produce areas with high excitability or 
12 
 
ectopic electrogenesis and lead to increased non-functional crosstalk between axons.
85
 
Residual limb pain and phantom limb pain are two general kinds of chronic pain in 
amputee patients that can be largely attributed to the supraspinal and peripheral 
mechanisms, respectively.
27,82,88
 Residual limb pain is usually a nociceptive pain 
associated with irritation or inflammation in the residual limb caused by external (e.g. 
surgery, misfit socket) or internal (e.g. referral pain from other body-parts) stimulations.
89
 
Residual limb pain could be associated with the surgical procedure due to physical 
damage to the body tissues, especially at its distal end.
89
 In some cases, the residual limb 
pain is neuropathic and associated with a neural deficit such as a neuroma 
formation.
81,90,91
 Overall, the six most common causes of the residual limb pain are 
attributed to the prosthogenic (i.e. misfitting of a prosthesis), neurogenic, arthrogenic, 
sympathogenic, referred, and abnormal residual limb tissues.
85
 The prosthogenic cause of 
the residual limb pain refers to problems with the fit and design of a prosthetic socket 
(e.g. when the socket walls are too tight or too loose or have inappropriate trim lines and 
rims), distal end weight bearing design, and an inappropriate suspension system.
43,85
 The 
neurogenic cause of the residual limb pain refers to the neurotemesis following 
amputation and development of the neuromas.
92
 Neuromas are sensitive and can trigger 
in response to muscle activation, external forces, and even without any internal or 
external stimuli.
92
 Arthrogenic residual limb pain is pain arising from a joint (e.g. from 
knee osteoarthritis) or its diseased adjacent soft tissues like tendons, ligaments, and 
synovial membranes.
93,94
 Sympathetically maintained pain is fairly common and could be 
another cause of the residual limb pain with clinical features of a neuropathic pain like 
burning, shooting, and stabbing.
85
 Radiculopathy, myofascial pain and pain arising from 
13 
 
facet joints of the vertebra, and muscle could be other sources of the residual limb 
pain.
27,95-97
 Myofascia, which is a dense connective tissue innervated by sensory neurons 
(nociceptors), responds to injury, postural stress, and inactivity by bonding to other 
tissues that consequently, leads to formation of hypersensitive tender spots.
97
 Therefore, 
adhesive myofascial spots can be a source of the residual limb pain. Smith et al (1999) 
found from a survey of 92 lower limb amputees that back pain was prevalent among 
amputees and could be more bothersome than phantom limb pain and residual limb 
pain.
98
 The residual limb tissues including fat, bone, muscle, and skin could lead to 
painful conditions. Some of the most reported abnormalities include bony exostoses, 
heterotrophic ossification, soft tissue scars and ulcers, fat in atrophied muscles, 
osteomyelitis and residual graft infections, ischemia and hematoma.
27,85,92
 The majority 
of patients after a partial or complete amputation of a limb may feel that the amputated 
part of the body is still present and suffer from pain. Phantom limb pain is a neuropathic 
pain located at the missing body part and is thought to result from alterations in the 
central and peripheral nervous system.
73,81,82,89,99
 The first medical description of phantom 
pain goes back to the sixteenth century when a French military surgeon, Ambroise Pare, 
noticed recurrent complaints of severe pain at the missing part of the amputated limb.
89
 In 
spite of the ample literature on phantom pain, there is no consensus on the exact 
mechanism of such a feeling. In the literature, phantom pain has been attributed to 
genetic background, memories, neuromas (the painful end branches of a cut nerve), 
peripheral/spinal dysfunction, supraspinal and central plasticity, and cortical re-
mapping.
100,101
 The existence of pre-amputation pain, stress, depression and other 
emotional triggers can increase the risk of phantom pain. Moreover, physical factors (e.g. 
14 
 
referred sensation), psychological factors (e.g. thinking about the amputation), and 
weather-induced factors (e.g. temperature fluctuations) can trigger phantom pain.
101
 
Phantom pain in 50% of the cases is intermittently episodic versus a constant pain. 
Episodes of intermittent phantom pain can range from hours, days, weeks, and years, to 
decades.
102
 Although phantom limb pain typically happens in the first six months after 
amputation surgery, several studies reported its high occurrence years after amputation 
surgery.
86,102,103
   
Residual limb pain and phantom limb pain are prevalent after amputation 
surgeries. Kooijman et al, determined that the prevalence of phantom limb pain and 
residual limb pain is 51% and 47%, respectively.
104
 Sherman et al found that 78% of their 
participant amputees had complaints of phantom pain.
102
 The prevalence of phantom pain 
is higher in women, as well in amputees with upper extremity amputations. The range of 
prevalence for the residual limb pain and phantom limb pain after upper extremity 
amputation was reported from 7% to 49% and 30% to 79%, respectively.
105
 In another 
study, the rate of phantom limb pain and residual limb pain was reported 71% and 78%, 
respectively among veterans who were injured in the war zones of the Kurdistan.
106
 One 
of the main sources of residual limb pain is skin dermatoses ranging from 34 to 74% in 
amputees.
90,107
 Yang and her coauthors reported existence of residual limb pain in 61.5% 
of their 247 participant amputees.
91
 It has been shown that many amputees who suffer 
from phantom limb pain, also report residual limb pain as a result of the difficulty in 
distinguishing between these two different types of pain.
104
 Sherman and Sherman (1983) 
found 61% of 648 veteran amputees with residual limb pain also suffered from phantom 





Indeed, in the majority of amputees, phantom limb pain and residual limb pain coexist 
and have a significant correlation in their intensity.
27,38
 In addition to residual limb pain 
and phantom limb pain, many people with amputation experience ambiguous pain in their 
residual limb.
5,34
 Moreover, environmental, social, and economic factors can influence 




1.8. Pain Management After Amputation 
A variety of pain management strategies of the healthy and intact persons were applied 
over the past few decades with different success rates in amputees. Still, there are many 
potential techniques and strategies that can be applied to alleviate post-amputation pain. 
Pain management after amputation can be classified into three categories, which include 
medical, non-medical, and surgical treatments. Surgical treatment is an invasive method 
that is usually considered as the last choice. Cordotomy, root lesions, targeted nerve 
implantation and targeted muscle reinnervation are common surgical procedures to 
prevent or decrease stump and phantom pains.
108-110
 Targeted nerve implantation and 
targeted muscle reinnervation are based on the same principles of transferring the 
resected nerve and rely on a surgically denervated muscle to reinnervate instead of 
neuroma formation.
108
 In spite of high similarity of the two procedures there are some 
differences between them. Targeted muscle reinnervation is distinct due to employment 
of much more formal and proximal nerve transfers into defined muscle segment to obtain 
robust muscle signals.
108
 The longevity of pain relief after surgical treatment is not high 
and usually the neuroma will grow again after surgery.
101,111,112
 Motor cortex stimulation 
as an intracranial and invasive method, when delivered in the awakened situation during 
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operation, was shown to have promising results in treatment of post-amputation pain. 
This technique needs prior functional MRI to localize the pain site over the cortex and 
then directly triggering the reorganization cortical map.
27
 It was reported that pain relief 
after this technique lasted from 6 months to 10 years after amputation.
27
 The brain has the 
ability to inhibit the transmission of pain signals monoaminergically using monoamine 
transmitters like norepinephrine and serotonin.
113
 Therefore, many medications can be 
used to alter the distribution of monoamines in body and affect pain perception.
114
 
Although the most effective treatment for pain is medication therapy, it is associated with 
some drawbacks due to the drug side-effects.
27
 It has been reported that antibody-based 
medications (e.g. tumor necrosis factor alpha inhibitor and anti-nerve growth factor 
antibody) are the most safe and efficient treatment for the post-amputation pain.
115
 
Contrary to great drawbacks of medical and surgical treatments, non-medical treatments 
show some promising results. The most common non-medical treatments are using soft 
and rigid dressings to provide pain and edema control and prevent joint contracture.
116
 In 
addition, physical, massage, heat/cold, vibration and electroshock therapies, 
transcutaneous electrical nerve stimulation (TENS), acupuncture, hypnosis, and 
biofeedback (virtual reality methods such as mirror box therapy) are common for pain 
management.
73,85
 In addition to these non-medical treatments, some psychological and 
behavioral treatments have been introduced and proved to be effective for phantom pain 
relief. The mechanism of action of these treatments is invoking neural plasticity in 
amputees.
27
 Energy medicine by focusing on psychological trauma of the amputation, is a 
novel treatment for phantom pain.
117
 As a general consensus, the best outcome for 
phantom pain treatment can be obtained when physical, psychological and behavioral 
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treatments replace or substitute afferent signals from amputated limb.
101
 Although there 
are many conflicts in outcome results of non-medical treatments, they are more 
acceptable due to their few drawbacks. Using assistive devices/technologies and exercise 
therapy are examples of non-medical treatments to control pain.
110,118,119
 Usually a 
combination of different treatments can be used to alleviate pain after amputation. 
Moreover, in comparison to expanded body of evidence for pain management in healthy 
and intact people, there are limited practical and scientific reports for pain management in 
people with amputation. For example, the best practical massage and exercise technique 
to alleviate pain in amputees has not been established.
120
 However, it was reported in 
healthy individuals that massage therapy and mechanical pressure can neurologically, 
physiologically, and mechanically alleviate pain by inducing analgesic effects, increasing 
blood flow, and rearranging the muscle structure (fibers, connective tissues, and blood 
vessels), respectively.
97
 Similarly, myofascial release techniques were shown to be 
effective in pain reduction by promoting soft tissue extensibility, optimal muscle 
function, arterial dilation and vascular plasticity, and increased range of motion.
97
   
Conclusively, nonpharmacological approaches to alleviate pain need to be developed and 
tested in amputee people. Exercise, cognitive-behavioral therapies, yoga, acupuncture, 
chiropractic, and massage were previously used in intact population with different 
success rates of alleviating chronic pain.
97,119,120
 Further investigations of these 
approaches are warranted in amputees to alleviate their pain. 
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1.9. Pressure Algometry 
Pain is inherently subjective and its intensity is reliant on a person’s report.
121
 
Albeit self-reported pain intensity is valuable, it’s not a pure representation of the severity 
of pain. Indeed, self-reported pain intensity is a combination of the physiological, 
psychological, social, and health-related features of a person that make its interpretation 
difficult.
122
 Traditional ways to determine pain intensity by interview or self-
administration filling out of paper forms are to some extent inefficient and time 
consuming.
121
 In a focused systematic review by veteran affair’s pain measurement 
outcomes workgroup, it was shown that majority of the outcome measures of the 
musculoskeletal chronic pain had no key psychometric properties (minimal important 
difference, responsiveness, validity, and test-retest reliability).
123
 Objective pain 
assessment methods are more desirable and can be done using computers and 
technologies. In this way, researchers and clinicians can accelerate pain assessment in 
shorter time with higher accessibility.
121,122
 Thermal, electrical, chemical, and mechanical 
stimuli are different modalities that can be used for evaluation of pain perception.
124
 
Mechanical stimulus is the most favorable modality by researchers and clinicians and 
used frequently in mechanical pain assessments.
124,125
 Quantitative sensory testing, which 
works based on the determination of the pain threshold or stimulus response curves after 
sensory processes, is a valuable tool for the diagnosis, phenotype determination, and 
management of the post-amputation pain.
27
   
Pressure algometry is a reliable and responsive method to quantify pain by 
applying controlled pressure to a specific point of the body.
122,126
 Cuff algometry, 
pressure algometry, and computerized algometry are different methods to determine the 
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pressure pain threshold. Computerized algometry delivers indentation pressure using a 
mechanical arm and eliminates the operator effects on reaction time, randomisation of 
algometry points, alignment and rate of the indentation.
127
 Although pressure algometry 
and computerized algometry have comparable reliabilities, pressure algometry is 




Pressure algometry can be used to assess the sensation of different underlying 
tissues depending on the size of the algometer tip. For instance, the algometer tips of 0.2 
mm can be used for the measurement of the intra-epidermal nerve endings.
128
 However, it 
was reported that algometers with tip size of 1.6 mm or above can provide the summation 
of sensation from deeper tissues.
129




, and 2 
cm
2
 are the most commonly used algometer tips since they imitate the surface area of one 
or two finger tips.
130,131
 For reasons of simplicity, handheld digital algometer with a 1-
cm
2 
application surface area (Figure 2) is a frequently used device for pressure 
algometry.
130
 However, training for applying constant pressure, especially over multiple 
testing is required for efficient use of this device.
124
 The most reported pressure rate for 
the handheld algometer ranges from 0.05 to 20 Ns
-1
, while higher pressure rates may 
induce error in reading lower thresholds, as well as response time error and increased 
pressure peak and anxiety in repetitions.
124,132
   
The pressure pain threshold (PPT) is the lowest pressure an individual perceives 
as pain and discomfort.
16
 In other words, it’s the point at which a non-painful pressure 
stimulus turns into a painful pressure sensation.
126
 Pressure tolerance (PT) is the highest 





et al (1996) in a pressure algometry experiment over 14 trigger points of 30 patients with 
unilateral chronic pain found that painful body part is more sensitive to pressure than its 
contralateral side and PPT is higher in males than in the females.
133
 Moreover, they found 
that pressure tenderness was different over individual trigger points.
133
 Great variability 
(inter-individual differences) in PPT was reported in healthy individuals during pressure 
algometry.
134,135
 It was reported that PPT values decrease in the cephalic direction for 
trigger points over the spine as well as in the distal direction for trigger points over the 
upper limb.
133,134
 Interestingly, it was reported that nerve tissue had lower PPT values 
than adjacent muscle tissue.
134
 In another study in healthy individuals it was found that 
PPT decreased orderly during pressure algometry over nail bed to bony prominences to 
muscles.
135
 Moreover, except over muscles the lower limbs had higher PPT values than 
upper limbs.
135
 It was reported that great variability in PPT across healthy individuals can 
be anticipated, which normally deviates less than a factor of two of the group mean. With 
respect to the within subject variability, the PPT values have high reproducibility, which 
normally deviates less than 30% in repetitions.
135
   
Quantification of pain over the residual limb is challenging due to its direct 
contact to prosthetic socket, biomechanics of the interface, and fluctuating size (i.e. 
volume and shape) of the residual limb over short and long terms.
11
 Although there are 
numerous studies that focus on the residual limb-socket interface pressure measurements 
and estimation,
12-14
 the numbers of studies with focus on pain sensitivity of the residual 
limb skin are few.
15,16
 Pain sensitivity in amputees can be measured through skin 
indentation method by pressure pain algometry.
17
 Lee et al (2005) and Zhang and Lee 
(2006) used the indentation method in eight patients with transtibial amputation to 
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evaluate pain threshold and tolerance at 11 regions over the transtibial residual limb.
15,16
 
However, these studies did not include algometry for the distal end of the residual limb as 
a potential painful site of the transtibial residual limb.  
The relationship of amputees’ clinical and demographic characteristics with 
existence and intensity of the post-amputation pain could provide better insight over 
potential risk factors to occurrence and progress of post-amputation pain. However, the 
selected variables and the methods of assessment were not always the same. In a survey 
study, it was reported that there was no relationship of post-amputation pain with reasons 
of amputation, experience of using prosthesis, pain sensitivity, age, and years after 
amputation surgery.
38
 However, many studies lack the investigation of daily prosthesis 
use with residual limb pain or limb size fluctuations.
15,16,38
 
Classification of patients based on their phenotypic pain could provide better 
insight regarding the source of their pain and mechanism of their pain perception. It has 
been shown that individual variability in pain threshold and susceptibility can be 
attributed to the differences in genotypes or mutations in gene expression. This kind of 
information could be used to determine those with higher vulnerability to chronic pain 
development after amputation. Therefore, it would be possible to manage their pain by 
early therapeutic and clinical interventions.
27,136-138
 Another benefit of determination of 
pain variability among amputees is influencing the service delivery strategy and guiding 






Based on the gate control theory of pain, which was first introduced by Melzack 
and Wall (1965), signals which reach to the spinal cord and transmit to the supraspinal 
centers are modulated and controlled by other afferent signals and supraspinal centers, 
respectively.
139,140
 It means that while pain impulses are transmitting with unmyelinated 
and small myelinated fibers to the posterior horn of the spinal cord, simultaneous sensory 
inputs from larger myelinated fibers can disrupt or slow down the transmission of pain 
impulses.
140
 By reduction of ascending nociceptive signals, the descending pain 
inhibitory mechanism will be more prominent leading to an analgesic effect.
97,141
 
According to the gate control theory of pain, different kinds of physical stimuli can be 
applied to decrease pain perception in amputees. In this way, controlled pressure over the 
residual limb might have analgesic effect for post-amputation pain. This idea can describe 
why post-amputation pain was lower in those who used prosthesis earlier after 
amputation.
38
 The pressure stimuli can be delivered to the residual limb by walls of a 
prosthetic socket during standing and walking. Therefore, the importance of a good 
design and fit of the prosthesis over the residual limb is evident. With respect to the 
transtibial residual limb, it has a heterogeneous structure consisting of different 
underlying tissues with different thicknesses, blood perfusion rates, metabolic activities, 
and stress characteristics.
48
 Therefore, it seems reasonable to anticipate different 
behaviors of its soft tissue in response to physical stimuli at different locations. The 
knowledge of localized pain sensitivity and mechanisms that underlie pain perception in 
people with amputation could be used to improve the transtibial socket design and fit as 
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3.1. Abstract  
Purpose: Residual limb pain is common and jeopardizes general health and 
quality of life in amputees. Localization of pain sensitization has clinical practice 
implications, however, rarely been assessed in amputees. The objective of this study was 
to investigate the sensitivity of pain over the residual limb and its variability among 
veterans with transtibial amputation.  
Patients and methods: Pain sensitivity in 12 locations over transtibial residual 
limb was explored twice in 19 male veterans by determining their pressure pain threshold 
(PPT) and pressure tolerance (PT) using pressure algometry. Comparison of PPT and PT 
at each location within and between participants, and relationship of clinical and 
demographic characteristics with pain sensitivity were explored. 
Results: There were significant differences (p<0.05) between PPT and PT at mid-
patellar tendon, medial tibial flare, and distal end of the tibia. The lowest PPT and PT 
(20.5 and 33 Ncm
-2
, p=0.13) was recorded at the distal end of the residual limb, and the 
highest PPT and PT (73.4 and 94.3 Ncm
-2
, p=0.03) was recorded at the mid-patellar 
tendon. There was a significant moderate correlation (r=0.48-0.52) between pressure 
pain and daily hours of prosthesis use. There was no significant relationship between 
pressure pain and age, weight, height, body mass index (BMI), time after amputation, 
years of prosthesis use, and prosthesis type.   
Conclusion: Pressure-sensitive and pressure-tolerant areas over residual limb and 
variability of pressure pain among transtibial amputees were identified. Schematic 
representation of localized pain over the transtibial residual limb and daily usage of 
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prosthesis could be considered to improve the transtibial socket design and fit as well as 
the selection of prevention, therapeutic, and pain management strategies.  
 
3.2. Keywords 




According to the definition of the International Association for the Study of Pain 
(IASP), pain is an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage.
1
 Regardless of the exact 
cause, chronic pain is a devastating impairment that affects the whole life of a person.
2,3
 
Although complex, pain can be classified in 3 areas: nociceptive, neuropathic, and 
psychosocial.
4
 Acute pain is an immediate response to an injury or illness and will 
gradually resolve during healing process; however, chronic pain has a persistent nature 
and may remain for many years.
5
  
Residual limb pain and phantom limb pain are two general kinds of chronic pain 
in amputee patients.
6,7
 Residual limb pain is usually a nociceptive pain associated with 
irritation or inflammation in the residual limb caused by external (e.g. misfit socket) or 
internal (e.g. referral pain from other body-parts) stimulations.
8
 In some cases, the 
residual limb pain is neuropathic and associated with a neural deficit such as a neuroma 
formation.
5,9,10
 Phantom limb pain is a neuropathic pain located at the missing body part 





However, the exact mechanisms underlying phantom limb pain have not been determined 
yet.
11
 Neuropathic pain and post-surgical pain can lead to pain hypersensitivity, which 
may cause brain plasticity in pain sensation, trigger a transition from acute to chronic 
pain, and affect response to therapeutic techniques.
12,13
 In addition to residual limb pain 
and phantom limb pain, many people with amputation experience ambiguous pain in their 
residual limb.  
Pain in the residual limb may prevent amputees from participating in physical 
activity; consequently, their general health and quality of life may be jeopardized.
14,15
 
Information regarding sources of residual limb pain, associated factors, and quantification 
of pain could provide better insight for therapeutic and rehabilitative decision making.
16
 
Quantification of pain over the residual limb is challenging due to its direct contact to 
prosthetic socket, biomechanics of the interface, and fluctuating size (i.e. volume and 
shape) of the residual limb over the short and long term.
17
 Although there are numerous 
studies that focus on the residual limb-socket interface pressure measurements and 
estimation,
18-20




PPT and PT have been used as measures of pain sensitivity by pressure 
algometry, which is the quantification of pressure (force) applied to the skin to cause pain 
over specific points in the body.
23,24
 Lee et al (2005) and Zhang and Lee (2006) used the 
pressure algometry in eight patients with amputation to evaluate PPT and PT at 11 
regions over the transtibial residual limb.
21,22
 However, these studies did not include 
pressure algometry for the distal end of the residual limb as a potential painful site of the 
transtibial residual limb. Furthermore, these studies did not investigate a relationship of 
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the residual limb pain with daily prosthesis uses and limb size fluctuations. Daily 
fluctuations of the residual limb may lead to misfit issues in prosthesis users and 
consequently cause residual limb pain.
25
 Approximately, a mature transtibial residual 
limb has daily fluctuations of -2% to 12% of its volume.
17
 As confirmed earlier in 
patients with knee osteoarthritis,
13
 there is a possibility that PPTs and PT of the residual 
limb at different locations were due to hypersensitivity of the residual limb and 
neuroplasticity changes in pain perception (central sensitization).
12
 Therefore, 
investigation of residual limb pain outside of prosthetic interface could provide better 
insight about mechanisms of pain in people with amputation. The purpose of this study 
was to evaluate the pain sensitivity over the residual limb by PPT and PT to explore its 
diversity and location-dependent while there is no socket interface. In addition, this study 
evaluated the relationship of clinical and/or demographic characteristics with pain 
sensitivity in transtibial amputees.  
 
3.4. Material and Methods 
 
3.4.1. Participants 
Participants were sampled from the database of the Veterans and Martyrs Affair 
Foundation (VMAF) among veterans with unilateral transtibial amputation who were 
living in the Hamadan province of Iran. Veterans were called by phone and after 
describing the aim, process, and benefits of the study, were invited to participate. From 
the 28 volunteers who responded, 19 met the inclusion criteria and enrolled into the study 
(post statistical power analysis: 60%). The inclusion criteria were intact skin of the 
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residual limb, at least 25 cm length of the residual limb, and daily prosthesis use. The 
exclusion criteria were the existence of mental disorders (n=8), addictions (n=1), and 
neurological deficits. All participants were male and their mean age was 49.53 ± 10.70 
years. All aspects of the study were approved by the research ethics committee of the 
Veterans and Martyrs  Affair Foundation (Tehran, IR) with the approval number of: 
IR.ISAAR.REC.1398.016 (Appendix A). Furthermore, consistent with the  declaration of 
Helsinki, all aspects of the study and its aim were described to participants. Participants 
were informed that they were allowed to quit the study at any time. All participants gave 
written consent to participate in study. 
 
3.4.2. Pressure Algometry 
PPT and PT were evaluated by an examiner using a handheld digital algometer 
(FPIX 25, Wagner Instruments, Greenwich, Connecticut, USA). The instrument had a 
round, 1 cm
2 
rubber tip to transfer examiner load to test sites over the skin. The PPT is the 
lowest pressure an individual perceives as pain and discomfort. PT is the highest pressure 
that someone can tolerate (i.e. the pressure has become painful).
22
 Participants were 
trained to respectively say “enough” for painful feeling and “stop” for intolerable pain 
feeling. Each site was evaluated 4 times, 2 for pain threshold and 2 for pain tolerance, all 
in the same order. The examiner was trained to apply a constant and gradually increasing 
load of 5 Ns
-1
 at each test site until the participant felt pain. The amount of force was 




3.4.3. Sites of PPT and PT 
Twelve sites that most often are rectified during transtibial socket fabrication
26
 
were marked by a certified prosthetist on the residual limb for pressure algometry. These 
sites were mid-patellar tendon, tibial tuberosity, midshaft of the tibia, medial tibial flare, 
fibular head, distal end of the tibia, distal end of the fibula, distal end of the residual limb, 
midshank of the fibula, anterolateral of the tibia, anteromedial of the tibia, and lateral side 
of the popliteus muscle (Figure 3).  
 
3.4.4. Experimental Set Up 
In this cross sectional study, the same researcher surveyed participants regarding 
their demographic and clinical characteristics (age, weight, height, BMI, time after 
amputation, years of prosthesis use, daily prosthesis use, and prosthesis type) using a 
researcher designed questionnaire. The researcher checked participant compatibility with 
study criteria and then measured their weight and height using a scale and a stadiometer, 
respectively to calculate their BMI. The examiner asked participants to show up at the 
morning at the lab, remove their prostheses and rest half an hour on a chair. Thereafter, 
the participants were asked to select one of the two small folded papers with hidden 
labels of supine or prone on them to determine their first position for pressure algometry 
measurements. Therefore, participants were randomly laid in a supine or prone position 
to provide access to different sites for pressure algometry. After pressure algometry of all 
sites were collected in the supine or prone position, the participant was moved to the 
other position and pressure algometry was collected again at all of the sites.  
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The same researcher chose marked assessment sites randomly by chance for 
pressure algometry. Each PPT algometry was followed by 30 seconds of rest before PT 
algometry. The PT algometry continued by applying further load beyond the recorded 
PPT until the participant said “stop”. The amount of pressure was visually recorded from 
the screen of the device immediately after the participant said “enough” (PPT) or “stop” 
(PT). At each test site, after 2 minutes rest, PPT and PT evaluations were repeated. All 
pressure algometries were done in one session for each participant. Localized pain 
sensitivity was explored by PPT and PT comparison at each site. Moreover, variability of 
PPT and PT was explored among participants. Finally, the relationships of clinical and 
demographic characteristics with pain sensitivity were explored. 
 
3.4.5. Data and Statistical Analysis 
Clinical and demographic characteristics of participants, and their PPT and PT 
were measured. Statistical analyses were computed using SPSS software (Version 22.0, 
IBM Corp, New York, NY). The intra-day reliability of pressure algometry 
measurements was explored by calculating the intraclass correlation coefficient (ICC) of 
participants’ perceived pain during two trials, i.e. PPT and PT algometry. Independent t-
tests were used to identify differences between PPT and PT at different sites over the 
residual limb. The significant difference between PPT and PT at each location could be 
an indicator of appropriateness of the site for load bearing. Contrary, non-suitability of 
the site for load bearing could be concluded from non-significant difference between PPT 
and PT. Hence, PPT and PT over the residual limb had homogeneity variances (Levene’s 
p>0.05), the variability in each measure was explored separately by parametric one-way 
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analysis of variance (ANOVA). Tukey post-hoc analysis was used to identify differences 
among multiple pressure algometry sites. Furthermore, due to non-homogeny variances 
(Levene’s p<0.05), the variability of PPT and PT among participants were explored 
separately by non-parametric Kruskal-Wallis ANOVA. Pearson correlation coefficient 
and partial eta squared were calculated to explore potential relationship of PPT and PT 
values with numeric and nominate clinical and demographic variables, respectively. 




3.5.1. Clinical and Demographic Characteristics of Participants 
The clinical and demographic characteristics of participants are shown in Table 1. 
Most of the participants were amputated nearly 26 years ago and had nearly 25 years of 
experience in prosthesis use. Daily prosthesis use was about 10 hours for most of the 
participants. Approximately, 60% of participants had a right-sided transtibial residual 
limb.  
Research is generally difficult to conduct in veterans with a transtibial amputation 
because of their multiple injuries. In our sample, 37% of participants had cardiac, 
pulmonary or metabolic disorders or combination of these. Approximately, 70% of 
participants were retired or unemployed who preferred to receive compensation and 
pension from VMAF based on their disability rating. In respect to prosthesis type, 




3.5.2. Reliability of Pressure Algometry Measurements  
The reliability of pressure algometry measurements of participants’ perceived 
PPT (ICC(3,1)=0.996) and PT (ICC(3,1)=0.997) was high.  
 
3.5.3. Pain Sensitivity over the Transtibial Residual Limb 
The results of PPT and PT, as well as their comparison for each of the twelve sites 
over the transtibial residual limb are presented in Table 2. There were differences 
between PPT and PT at all twelve pressure algometry sites. However, the results of 
independent t-test showed that differences were significant (p<0.05) for only three sites: 
mid-patellar tendon, medial tibial flare, and distal end of the tibia. Moreover, the mean 
difference between PPT and PT had a range of 11 to 21 Ncm
-2
 at different test sites over 
the transtibial residual limb. Figures 4 and 5 provide sensitivity and variability of pain 
over the transtibial residual limb at each pressure algometry site. 
As presented in Figures 4 and 5, the lowest PPT and PT recorded at the distal end 
of the residual limb was 20.5 and 33 Ncm
-2
 (p=0.13) and the highest PPT and PT was 
recorded at the mid-patellar tendon, 73.4 and 94.3 Ncm
-2
 (p=0.03), respectively.  
 
3.5.4. Pain Variability in Pressure Algometry Sites and Among Participants with 
Transtibial Amputation 
The value of PPT and PT for each participant is presented in Table 3. The 
Levene's test for homogeneity of variances showed that PPT (Levene statistic=1.205, 
p=0.285) and PT (Levene statistic=0.538, p=0.876) had equal variances among pressure 
algometry sites. Therefore, parametric one-way ANOVA was used to explore variability 
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of PPT and PT over the residual limb. The results revealed there were significant 
differences among mean values of PPT (F(11,216)=5.279, p<0.05) and PT (F(11,216)=7.190, 
p<0.05) at different sites over transtibial residual limb. Tukey post-hoc analysis showed 
that the pressure algometry sites for the PPT and PT can be categorized in 6 and 5 
distinctly significant limits, respectively (Table 4, part A).  
Comparing participants, the Levene's test for homogeneity of variances showed 
that PPT (p<0.05) and PT (p<0.05) had unequal variances. Therefore, non-parametric 
Kruskal-Wallis one-way ANOVA test was used to compare variability of PPT and PT 
among participants. A Kruskal-Wallis one-way ANOVA test showed that there was a 
statistically significant difference in PPT (χ
2
(18)=36.526, p=0.006), and PT 
(χ
2
(18)=36.676, p=0.006) among participants. The mean rank of PPT and PT among 
participants are presented in Table 4, part B.  
 
3.5.5. Relationship of Pain Sensitivity with Clinical and Demographic 
Characteristics of Participants 
The results of Pearson correlation assessment of PPT and PT with clinical and 
demographic characteristics of participants are presented in Table 5. There were no 
significant correlations between pain sensitivity with participants’ age, weight, height, 
BMI, time after amputation, and years of prosthesis use. However, daily hours of 







3.6.1. Pain Sensitivity over the Transtibial Residual Limb 
PPT and PT were evaluated using pressure algometry at 12 sites over transtibial 
residual limb. The results confirmed variability of PPT and PT over the residual limb. 
The minimum of PPT and PT, as well as the maximum of PPT and PT were recorded at 
the distal end of the residual limb (20.5 and 33 Ncm
-2
) and mid-patellar tendon (73.4 and 
94.3 Ncm
-2
), respectively. This finding is in agreement with Zhang and Lee (2006) and 
Lee et al (2005) who found that the maximum PPT and PT site was at the mid-patellar 
tendon; however, the site for the lowest PPT and PT differs in comparison to their 
studies. They showed that the distal end of the fibula had the minimum PPT and PT.
21,22
 
Zhang and Lee (2006) and Lee et al (2005) evaluated pain at 11 sites over transtibial 
residual limb; however, our study explored pain at 12 sites. The distal end of the residual 
limb that had the lowest PPT and PT was an additional site evaluated in this study. 
During transtibial amputation surgery, a muscular flap should be added at the end of the 
residual limb below the tibia and fibula to provide muscular shock absorption, thus 
eliminating upward load transfer to residual bones. This flap forms the distal end of the 
residual limb approximately 3 to 5 cm below the distal end of the tibia and fibula. Our 
results showed that this flap had the lowest PPT and PT in transtibial residual limb, which 
was not assessed in previous reports.
21,22,27
        
To our knowledge, this study was the first to evaluate pain sensitivity at 12 
locations over the transtibial residual limb, and explore differences between PPT and PT 
at each location. The results showed that the mean difference between PPT and PT at 
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each site over the transtibial residual limb had a range of 11 to 21 Ncm
-2
, which was 
significant at mid-patellar tendon, medial tibial flare, and distal end of the tibia. This 
could be meant that these three sites had the highest pain tolerance (lowest pain 
hypersensitivity) of transtibial residual limb due to higher distance between their 
threshold and tolerance limits. On the other hand, the smaller differences at other sites 
between threshold and tolerance limits could be indicated as intolerable pain happens 
sooner after threshold limit. As indicated in Table 2, there were medium effect sizes (r= 
±0.3) in difference between the PPT and PT for most locations over the transtibial 
residual limb. Therefore, in spite of non-significant differences between PPT and PT for 
most locations, the amputee’s response to localized pressure over the transtibial residual 
limb is similar at most locations. These issues are more important in socket design, socket 
fit, and the pattern of pressure/shear distribution over the residual limb. Total surface 
bearing sockets, which were so popular among amputees and prosthetists were designed 
and fabricated by prosthetists to provide equal pressure/shear distribution over the 
residual limb. However, this design and fabrication process is continuously improving 
based on further evidences from residual limb behaviour under localized pressure.
26,28
 
The present study further supports the use of pressure algometry (i.e. skin pressure 
algometry to induce mechanical stimulus) as a reliable method (ICC(3,1)>0.995) to assess 






3.6.2. Pain Variability in Pressure Algometry Sites and Among Participants with 
Transtibial Amputation 
Variability tests showed there were significant differences between twelve 
pressure algometry sites over the transtibial residual limb. Moreover, post-hoc testing 
classified sites into four separate subclasses for PPT and PT. This finding revealed the 
complexity of the transtibial residual limb in respect to pressure pain responses, which 
could be related to the thickness and distribution of its underlying soft tissues, as well as 
localized hypersensitization. 
In spite of design differences between present study and previous studies,
21,22
 the 
mean values of PPT and PT were closer to those of the Lee et al (2005) study.
22
 The 











 However, Zhang and Lee 
(2006) reported higher values for PPT (56.72 Ncm
-2
) and PT (72.54 Ncm
-2
) in their 
study.
21
 Limited studies were focused on PPT and PT in amputee patients, however in 
healthy individuals great variability in PPT less than a factor of two of the group mean 
was reported.
29 
There were significant differences in the variability of PPT and PT among 
participants. The highest PPT and PT was seen in participant #18. By exploring his 
clinical and demographic characteristics, we noticed this participant had the highest level 
of prosthesis use per day (18 h). On the other hand, the lowest PPT and PT was recorded 
in participant #3. Interestingly, this participant had the most recent amputation surgery 
and the lowest duration (experience) of prosthesis use (3 y). However, the correlation 
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between pain sensitivity and time after surgery as well as years of prosthesis use was not 
significant.  
 
3.6.3. Relationship of Pain Sensitivity with Clinical and Demographic 
Characteristics of Participants 
Our study found no significant relationships between pain sensitivity and 
participants’ age, weight, height, BMI, time after amputation, or years of prosthesis use. 
In respect to age, our finding was in agreement with that of Ephraim et al (2005), and in 
disagreement with that of Lee et al (2005).
6,22
 The contrary finding of relationship 
between participant’s age and residual limb pain can be attributed to differences in 
participants. In our study participants were younger and their amputation cause was 




There was a significant correlation between residual limb pain sensitivity and 
daily hours of prosthesis use (p<0.05). This finding was likely related to daily 
fluctuations of the residual limb size. Interestingly, the type of prosthesis and the years of 
using prosthesis had no relationship with the PPT or PT. 
 
3.6.4. Study Limitations 
There were several limitations in our study. Because this study was limited to 
veterans, the results may not be generalizable to other transtibial amputee populations due 
to complexity of the associated injuries and disorders in veterans. In addition, 
participation of just male veterans is another limitation due to substantial gender 
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differences in PPT and PT.
30
 This study had no control on type of amputation surgery in 
respect to kind of nerve block to decrease the chance of neuroma formation, vascularity 
of the residual limb, tapering shape of the distal part of the residual tibia and/or fibula, 
distal flap of the soft tissue, and sutures, which all could influence the results.
31
 Hence, 
post-amputation edema in early months after surgery is an intervening parameter in 
inducing and increasing pain,
31
 care should be taken in comparing our findings with those 
amputees. Finally, the design of pain sensitivity and variability assessment in this study 
lacked consideration of potential daily fluctuations of the mature transtibial residual limb, 
which could potentially affect the results.
17
      
 
3.6.5. Opportunities for Future Research 
This study may also lead to opportunities for further research for interventions 
such as exercise that may improve pain sensitivity in lower extremity amputees.
32
 
Desensitizing methods such as vibration therapy and specific exercises could increase 
PPT and PT over time;
33
 therefore, an investigation about pain sensitivity and variation in 
people with amputation after exercise therapy is warranted. Furthermore, the current 
study did not compare pressure algometry of the contralateral intact side to the amputated 
side. A comparison between these limbs may provide better insight on underlying 
peripheral and central sensitizations in amputees, and further investigation with this 
regard is required. Following amputation, the residual limb is the interface of body with 
the environment and is responsible for transferring loads and movements. However, its 
structure is not well adapted to this responsibility. Therefore, further research on 
determination of safe and comfortable pressure limits of the transtibial residual limb 
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during activities of daily living with and without weight bearing is warranted. Such 
information could improve rehabilitation techniques for amputees by increasing their 
functionality and participation. Ultrasonography to quantify the depth of the residual limb 
tissue, and examining the relationship between residual tissue thickness and pain 
sensitivity may provide implications for salvage techniques. Pain assessment in a larger 
sample of amputees while controlling variations of the amputation surgery could provide 
better insight regarding threshold and tolerance limits. 
  
3.7. Conclusions 
PPT and PT over the transtibial residual limb identified the sensitivity of different 
anatomical locations of the residual limb to pain. Longer daily usage of the prosthesis led 
to increased pressure pain sensitivity; therefore, residual limb pain, daily usage of 
prosthesis, and the schematic representation of localized pain over the transtibial residual 
limb could be used to improve the transtibial socket design and fit as well as the selection 
of prevention, therapeutic, and pain management strategies. Improving the prosthetic 
socket design with the possibility of adaptation to the daily fluctuations of the residual 
limb could possibly alleviate pain in people with transtibial amputation.  
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Table 1. Clinical and demographic characteristics of participants (N=19)‎ 
Variable Data Range Mean Standard Deviation (SD) 
Age 23-64 49.5 10.7 
Weight (kg) 60-93 79.9 9.6 
Height (cm) 156-205 171.7 9.9 
BMI (kgm
-2
) 22.1-34.7 27.2 3.3 
Time after Amputation (y) 4-34 25.8 8.8 
Years of Prosthesis Use (y) 3-34 25.3 8.9 
Daily Prosthesis Use (h) 3.5-16 10.2 3.4 
Employment Status* 
E: n=5 
*Un-E: n=14   
Amputation Side 
R: n=11 















Abbreviations: *Un-E, unemployed (retired or unemployed veterans and veterans who 
received compensation and pension from Veterans and Martyrs Affair Foundation 
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(VMAF) based on their disability rating considered unemployed; R, right side; L, left 
side; E, employed; C, cardiac disorder; M, metabolic disorder; P, pulmonary disorder; 
Ex-P, exoskeletal with polyfoam liner; En-P, endoskeletal with polyfoam liner; En-S, 




Table 2. The levels (Mean±SD) of pressure pain threshold (PPT) and pressure 
tolerance ‎(PT) for twelve sites over transtibial residual limb‎ 
Location of Assessment 























73.4±31.0 94.3±27.1 -20.9 -2.2 0.3 -40.0 -1.7 0.03* 
Tibial Tuberosity 63.9±31.0 78.6±26.5 -14.7 -1.6 0.3 -33.7 4.2 0.12 
Midshaft of the Tibia 54.2±29.0 70.5±27.4 -16.3 -1.8 0.3 -34.8 2.3 0.08 
Medial Tibial Flare 48.5±27.9 69.5±29.4 -21.0 -2.3 0.4 -39.8 -2.2 0.03* 
Fibular Head 47.2±23.3 60.8±22.6 -13.5 -1.8 0.3 -28.7 1.6 0.08 
Distal End of the Tibia 39.9±23.5 57.1±25.5 -17.2 -2.2 0.3 -33.3 -1.1 0.04* 
Distal End of the Fibula 35.2±25.5 47.9±25.9 -12.7 -1.5 0.2 -29.6 4.2 0.14 
Distal End of the 
Residual Limb 
20.5±24.2 33.0±26.3 -12.5 -1.5 0.2 -29.2 4.1 0.13 
Midshank of the Fibula 34.3±24.3 45.7±27.4 -11.3 -1.4 0.2 -28.4 5.7 0.18 
Anterolateral of Tibia 38.5±22.2 51.7±25.2 -13.2 -1.7 0.3 -28.8 2.5 0.10 
Anteromedial of Tibia 42.5±24.2 54.3±25.0 -11.8 -1.5 0.2 -28.0 4.4 0.15 
Lateral Side of 
Popliteus Muscle 





: Effect size; *: difference is statistically significant (p<0.05).  
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Table 3. The values (Mean±SD) of pressure pain threshold (PPT) and pressure 
tolerance ‎(PT) during two trials and overall pain value for each participant‎ 
Participant 
PPT (Ncm-2) PT (Ncm-2) 
Trial 1 Trial 2 Overall Trial 1 Trial 2 Overall 
1 32.6±11.6 32.3±12.0 32.5±11.8 47.3±25.3 49.9±22.7 48.6±24.0 
2 34.1±16.9 34.3±16.6 34.2±16.8 42.9±18.1 43.8±17.1 43.4±17.6 
3 20.6±4.3 20.6±4.1 20.6±4.2 30.8±8.2 31.8±7.2 31.3±7.7 
4 32.4±12.1 31.9±11.7 32.1±11.9 44.3±17.0 45.6±15.6 45.0±16.3 
5 26.0±7.5 26.3±7.7 26.1±7.6 38.3±8.4 39.7±7.9 39.0±8.1 
6 37.8±18.9 38.0±19.3 37.9±19.1 49.9±23.9 50.1±22.8 50.0±23.4 
7 41.1±20.2 48.3±32.3 44.7±26.3 70.0±33.4 72.4±30.1 71.2±31.8 
8 22.5±7.9 23.2±8.5 22.9±8.2 31.3±14.0 31.6±13.6 31.5±13.8 
9 61.3±29.1 64.6±28.9 63.0±29.0 82.3±27.1 82.4±26.5 82.4±26.8 
10 45.5±18.7 45.3±18.5 45.4±18.6 66.8±21.3 65.2±20.1 66.0±20.7 
11 69.2±20.3 69.0±19.1 69.1±19.7 97.3±16.8 101.0±18.8 99.1±17.8 
12 87.4±29.9 86.4±30.7 86.9±30.3 93.0±23.0 93.4±21.6 93.2±22.3 
13 33.3±17.7 32.6±17.7 33.0±17.7 49.0±27.8 47.7±25.8 48.4±26.8 
14 31.8±18.0 33.2±17.6 32.5±17.8 52.8±25.6 48.3±26.7 50.5±26.1 
15 30.1±12.8 30.4±12.3 30.2±12.6 55.3±19.1 56.2±17.7 55.7±18.4 
16 48.2±33.4 48.6±33.0 48.4±33.2 61.4±31.0 61.4±30.0 61.4±30.5 
17 45.6±25.8 45.3±27.9 45.4±26.8 58.8±26.5 59.5±24.9 59.2±25.7 
18 105.0±27.2 105.2±30.7 105.1±28.9 111.5±8.8 111.5±8.4 111.5±8.6 
19 50.8±19.1 48.6±17.7 49.7±18.4 60.0±17.4 60.6±17.5 60.3±17.5 
Mean±SD 45.0±22.1 45.5±22.1 45.2±22.1 60.2±22.3 60.6±22.5 60.4±22.4 
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Table 4. Variability of pressure pain threshold (PPT) and pressure tolerance (PT) 
at ‎algometry sites (Part A) and among participants (Part B)‎ 
Part A: Classification of algometry sites based on their variability (Note: sites under each class have no significant 
difference with each other, however there is significant difference (p<0.05) between classes) 
PPT (Ncm-2) PT (Ncm-2) 
Class 1 Class 2 Class 3 Class 4 Class 1 Class 2 Class 3 Class 4 
8    8    
9 9   9 9   
7 7   7 7   
10 10 10  10 10 10  
6 6 6  11 11 11  
11 11 11  6 6 6  
12 12 12  5 5 5  
5 5 5 5  12 12  
4 4 4 4  4 4 4 
 3 3 3  3 3 3 
  2 2   2 2 
   1    1 
1) Mid-patellar Tendon; 2) Tibial Tuberosity; 3) Midshaft of the Tibia; 4) Medial Tibial Flare; 5) Fibular Head; 6) 
Distal End of the Tibia; 7) Distal End of the Fibula; 8) Distal End of the Residual Limb; 9) Midshank of the Fibula; 10) 
Anterolateral of Tibia; 11) Anteromedial of Tibia; 12) Lateral Side of Popliteus Muscle. 
































































































































































































Table 5. The results of correlation assessment between mean of pressure pain 
threshold ‎(PPT) and pressure tolerance (PT) with clinical and demographic 


















s Use (y) 
Daily 
Prosthesi







0.11 0.30 0.06 0.27 -0.06 -0.04 0.52* 0.05 




0.13 0.31 0.02 0.31 -0.09 -0.06 0.48* 0.10 
p 0.61 0.20 0.93 0.20 0.72 0.81 0.04 0.45 
 
Notes: 
*: Correlation is statistically significant; 
a
: Pearson’s r; 
b





Figure 1. Exoskeletal (A) and endoskeletal (B) designs of the transtibial ‎prosthesis 











1) Mid-patellar Tendon; 2) Tibial Tuberosity; 3) Midshaft of the Tibia; 4) Medial Tibial 
Flare; 5) Fibular Head; 6) Distal End of the Tibia; 7) Distal End of the Fibula; 8) Distal 
End of the Residual Limb; 9) Midshank of the Fibula; 10) Anterolateral of Tibia; 11) 
Anteromedial of Tibia; 12) Lateral Side of Popliteus Muscle. 



























1) Mid-patellar Tendon; 2) Tibial Tuberosity; 3) Midshaft of the Tibia; 4) Medial Tibial 
Flare; 5) Fibular Head; 6) Distal End of the Tibia; 7) Distal End of the Fibula; 8) Distal 
End of the Residual Limb; 9) Midshank of the Fibula; 10) Anterolateral of Tibia; 11) 
Anteromedial of Tibia; 12) Lateral Side of Popliteus Muscle; *: difference is statistically 
significant (p<0.05). 






















1) Mid-patellar Tendon; 2) Tibial Tuberosity; 3) Midshaft of the Tibia; 4) Medial Tibial 
Flare; 5) Fibular Head; 6) Distal End of the Tibia; 7) Distal End of the Fibula; 8) Distal 
End of the Residual Limb; 9) Midshank of the Fibula; 10) Anterolateral of Tibia; 11) 
Anteromedial of Tibia; 12) Lateral Side of Popliteus Muscle; *: difference is statistically 
significant (p<0.05). 
Figure 5. Pressure tolerance at different sites over ‎the transtibial residual limb 
 
 
